Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · IEX Real-Time Price · USD
4.980
-0.180 (-3.49%)
Jul 22, 2024, 10:00 AM EDT - Market open
Prelude Therapeutics Employees
Prelude Therapeutics had 128 employees as of December 31, 2023. The number of employees increased by 6 or 4.92% compared to the previous year.
Employees
128
Change (1Y)
6
Growth (1Y)
4.92%
Revenue / Employee
n/a
Profits / Employee
-$980,820
Market Cap
283.44M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 128 | 6 | 4.92% |
| Dec 31, 2022 | 122 | 6 | 5.17% |
| Dec 31, 2021 | 116 | 48 | 70.59% |
| Dec 31, 2020 | 68 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Accolade | 2,400 |
| AngioDynamics | 815 |
| MeiraGTx Holdings | 425 |
| LifeMD | 211 |
| Omeros | 198 |
| Akebia Therapeutics | 167 |
| Alimera Sciences | 159 |
| Orchestra BioMed Holdings | 56 |
PRLD News
- 13 days ago - Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination with KEYTRUDA® (pembrolizumab) in Patients with SMARCA4-Mutated Cancers - GlobeNewsWire
- 7 weeks ago - Prelude Therapeutics to Participate in Upcoming Healthcare Conferences - GlobeNewsWire
- 2 months ago - Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference - GlobeNewsWire
- 2 months ago - Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting - GlobeNewsWire
- 4 months ago - Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting - GlobeNewsWire
- 5 months ago - Prelude Therapeutics to Participate in Barclays Global Healthcare Conference - GlobeNewsWire
- 5 months ago - Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024 - GlobeNewsWire